MEDINET Japan inks licensing pact with Stempeutics India for Stempeucel® therapy to treat Chronic Limb Threatening Ischemia
Tokyo-based regenerative medicine company MEDINET Co., Ltd. (2370.T) has signed an Option License Agreement with Stempeutics Research Pvt. Ltd., a […]
